BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
198 results:

  • 1. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma.
    Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Carcinoma showing thymus-like elements (CASTLE) with amyloid deposition in the parotid gland.
    Hamada M; Miyama Y; Matsumura S; Shintani-Domoto Y; Urano M; Yasuda M
    Pathol Int; 2024 Apr; 74(4):227-233. PubMed ID: 38488752
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
    Gharzai LA; Morris E; Suresh K; Nguyen-Tân PF; Rosenthal DI; Gillison ML; Harari PM; Garden AS; Koyfman S; Caudell JJ; Jones CU; Mitchell DL; Krempl G; Ridge JA; Gensheimer MF; Bonner JA; Filion E; Dunlap NE; Stokes WA; Le QT; Torres-Saavedra P; Mierzwa M; Schipper MJ
    Lancet Oncol; 2024 Mar; 25(3):366-375. PubMed ID: 38423050
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Methods for detection of mitochondrial reactive oxygen species in senescent cells.
    Salma F; Yassire O; Youssef B; Corinne D; Ameziane El Hassani R
    Methods Cell Biol; 2024; 181():33-41. PubMed ID: 38302242
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
    Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
    Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic profiling of primary and metastatic thyroid cancers.
    Máximo V; Melo M; Zhu Y; Gazzo A; Sobrinho Simões M; Da Cruz Paula A; Soares P
    Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 38015791
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
    Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
    BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
    Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
    Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnosis and Prognosis of thyroid cancer by Immune-related Genes.
    Li J; Li Z; Zhao P
    Am J Clin Oncol; 2024 Jan; 47(1):1-10. PubMed ID: 37779238
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunoreactivity of TTF-1, GATA-3, CEA, and p16/Ki67 cocktail in Cellprep®-processed control samples: Comparison of long-term storage in vials and slides.
    Ryu A; Honma K; Umeno Y; Uefuji F; Muramatsu T; Nishimura S; Tanada S; Yamamoto T; Nagata S; Yamasaki T; Ohue M
    Diagn Cytopathol; 2024 Jan; 52(1):3-9. PubMed ID: 37740615
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Organochlorine pesticides and epigenetic alterations in thyroid tumors.
    Salimi F; Asadikaram G; Ashrafi MR; Zeynali Nejad H; Abolhassani M; Abbasi-Jorjandi M; Sanjari M
    Front Endocrinol (Lausanne); 2023; 14():1130794. PubMed ID: 37560303
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. D898_E901
    Porcelli T; Moccia M; De Stefano MA; Ambrosio R; Capoluongo E; Santoro M; Hadoux J; Schlumberger M; Carlomagno F; Salvatore D
    JCO Precis Oncol; 2023 Aug; 7():e2300052. PubMed ID: 37535881
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
    Zhu M; Li J; Zheng WH; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
    [No Abstract]    [Full Text] [Related]  

  • 14. Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature.
    Giannini L; Alliata A; Cristofaro V; Incandela F; Pompilio M; Ottini A; Cavalieri S; Nuzzolese I; Iacovelli NA; Franceschini M; Deganello A
    Curr Oncol; 2023 Jul; 30(7):6708-6719. PubMed ID: 37504352
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis.
    Panagopoulos I; Andersen K; Brunetti M; Gorunova L; Davidson B; Lund-Iversen M; Micci F; Heim S
    Cancer Genomics Proteomics; 2023; 20(4):363-374. PubMed ID: 37400148
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. p18ink4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
    Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
    Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
    Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
    Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
    Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular Genetics of Diffuse Sclerosing Papillary thyroid cancer.
    Alswailem M; Alghamdi B; Alotaibi A; Aljomiah A; Al-Hindi H; Murugan AK; Abouelhoda M; Shi Y; Alzahrani AS
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e704-e711. PubMed ID: 36995892
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Two distinct pathogenic pathways of digital papillary adenocarcinoma - BRAF mutation or low-risk HPV infection.
    Bui CM; Pukhalskaya T; Smoller BR; Zengin HB; Heneidi S; Vail E; Makhoul E; Balzer B
    J Cutan Pathol; 2023 Jun; 50(6):568-576. PubMed ID: 36756976
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.